Silke Müller

Dr. Silke Müller

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2005 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
SMSilke Müller
Silke Müller
JMJolanta Majcher-Peszynska
Jolanta Majcher-Peszynska
BUBernhard Uehleke
Bernhard Uehleke
SKSebastian Klammt
Sebastian Klammt
RMRalf G. Mundkowski
Ralf G. Mundkowski
BDBernd Drewelow
Bernd Drewelow

2 May 2002 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
SMSilke Müller
Silke Müller
JMJolanta Majcher-Peszynska
Jolanta Majcher-Peszynska
HHHeiko Hickstein
Heiko Hickstein
AFAstrid Francke
Astrid Francke
APAnnette Pertschy
Annette Pertschy
BDBernd Drewelow
Bernd Drewelow
The pharmacokinetics of piperacillin-tazobactam were investigated in eight anuric intensive care patients treated by continuous venovenous hemodialysis (CVVHD). The elimination half-life of piperacillin was 4.3 ± 1.2 h, and that of tazobactam was 5.6 ± 1.3 h. The contribution of CVVHD to the overall elimination was relevant (>25%) for both drugs.

3 September 2008 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
SMSilke Müller
Silke Müller
JMJolanta Majcher-Peszynska
Jolanta Majcher-Peszynska
RMRalf G. Mundkowski
Ralf G. Mundkowski
BUBernhard Uehleke
Bernhard Uehleke
SKSebastian Klammt
Sebastian Klammt
BDBernd Drewelow
Bernd Drewelow

20 April 2012 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
SMSilke Müller
Silke Müller
RMReinhard März
Reinhard März
MSManfred Schmolz
Manfred Schmolz
BDBernd Drewelow
Bernd Drewelow
KEKlaus Eschmann
Klaus Eschmann
MPMeiser Peter
Meiser Peter

1 August 2012 in BMC Medical Research Methodology
Verified
Journal Article
Open access
PDF file
SMSilke Müller
Silke Müller
RMReinhard März
Reinhard März
MSManfred Schmolz
Manfred Schmolz
BDBernd Drewelow
Bernd Drewelow
The variation of immune cell activities over time is an immanent property of the human immune system, as can be measured by the stimulated secretion of cytokines in cell cultures. However, inter-individual variability is considerably higher. Especially the latter is the major reason why it has not been possible to establish international standard values for cytokines as was possible for other parameters, such as leukocyte sub-population numbers. In this trial, a highly standardized whole-blood culture model (TrueCulture®), developed to characterise drug effects on cells of the human immune system in clinical trials, was used to analyse cytokine patterns in the blood samples of 12 healthy subjects over a period of one month.

21 May 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
AEAndreas Enz
Andreas Enz
SMSilke Müller
Silke Müller
PWPhilipp Warnke
Philipp Warnke
MEMartin Ellenrieder
Martin Ellenrieder
WMWolfram Mittelmeier
Wolfram Mittelmeier
AKAnnett Klinder
Annett Klinder
The treatment of periprosthetic joint infections (PJI), and especially of re-infections, poses a highly complex problem in orthopaedic surgery. While fungal infections are rare, they present a special challenge. The therapy is often protracted and based on limited evidence. A total of 510 hip and knee revision surgeries were analysed for the occurrence of bacterial and fungal PJI. In patients with PJI, the duration of the hospital stay and the incidence of disarticulation of the infected joint were recorded. Out of the analysed revision arthroplasties, 43.5% were due to PJI. Monomicrobial infection occurred in 55.2%, dual microbial infection in 21.4%, and polymicrobial (≥3 different bacterial or fungal species) infection in 17.2% of the cases. Overall, Candida species were detected in 12.4% cases. Candida albicans was the main fungal pathogen. In 6.9% of cases, disarticulation of the joint was the only option to control PJI. The detection of polymicrobial infection more than doubled in follow-up revisions and there was a strong association between detection of Candida infection and disarticulation (OR 9.39). The majority of fungal infections were mixed infections of bacteria and Candida albicans. The choice of a biofilm penetrating antimycotic, e.g., caspofungin, together with a sufficient standard procedure for detection and surgical treatment can help to control the infection situation. Fungal infection often proves to be more difficult to treat than anticipated and is more frequent than expected.